Introduction: 18q deletion syndrome is a rare genetic disorder characterized by various neurodevelopmental anomalies and medical issues. Although the occurrence of psychosis has been reported in a small number of cases, details regarding the nature of such symptoms and their response to treatment have not been described. Case Presentation: We describe a 31-year-old male with a history of speech delays, autistic features, a tethered spinal cord, bilateral vertical talus, subaortic stenosis and aortic regurgitation, recurrent otitis media, mild hearing loss, and hypospadias, who experienced a first episode of psychosis in his late 20s. His psychotic symptoms included auditory hallucinations, various delusions, and disorganization of thought. Although his presentation is atypical in certain ways (e.g., exhibiting highly fluctuant symptoms), he nonetheless meets criteria for schizophrenia. Given his overall clinical picture, chromosomal microarray analysis was completed, which revealed a 19.78 Mb deletion at 18q21.32 from nucleotide 58,226,713 to 78,015,180 (GRCh37). Despite exhibiting a somewhat idiosyncratic response to numerous antipsychotic medications, he eventually achieved partial remission of symptoms with improved insight on relatively low dose oral aripiprazole therapy. Conclusion: This is the first in-depth description of 18q deletion syndrome-associated schizophrenia. While our patient’s atypical presentation and idiosyncratic response to treatment may be mediated by his comorbid diagnosis of autism, his unusual psychiatric phenotype may alternatively be directly related to his underlying genetic disorder. The description of additional cases in the future will hopefully help clarify matters further.

1.
Cody
JD
,
Sebold
C
,
Heard
P
,
Carter
E
,
Soileau
B
,
Hasi-Zogaj
M
, et al
.
Consequences of chromsome18q deletions
.
Am J Med Genet C Semin Med Genet
.
2015
;
169
(
3
):
265
80
.
2.
Mahr
RN
,
Moberg
PJ
,
Overhauser
J
,
Strathdee
G
,
Kamholz
J
,
Loevner
LA
, et al
.
Neuropsychiatry of 18q- syndrome
.
Am J Med Genet
.
1996
;
67
(
2
):
172
8
.
3.
Donnai
D
.
Gene location in Tourette syndrome
.
Lancet
.
1987
;
1
(
8533
):
627
.
4.
Zavala
J
,
Ramirez
M
,
Medina
R
,
Heard
P
,
Carter
E
,
Crandall
A
, et al
.
Psychiatric syndromes in individuals with chromosome 18 abnormalities
.
Am J Med Genet B Neuropsychiatr Genet
.
2010
;
153B
(
3
):
837
45
.
5.
Daviss
WB
,
O’Donnell
L
,
Soileau
BT
,
Heard
P
,
Carter
E
,
Pliszka
SR
, et al
.
Mood disorders in individuals with distal 18q deletions
.
Am J Med Genet B Neuropsychiatr Genet
.
2013
;
162B
(
8
):
879
88
.
6.
van Trier
DC
,
Feenstra
I
,
Bot
P
,
de Leeuw
N
,
Draaisma
JM
.
Cardiac anomalies in individuals with the 18q deletion syndrome; report of a child with Ebstein anomaly and review of the literature
.
Eur J Med Genet
.
2013
;
56
(
8
):
426
31
.
7.
Linnankivi
T
,
Tienari
P
,
Somer
M
,
Kahkonen
M
,
Lonnqvist
T
,
Valanne
L
, et al
.
18q deletions: clinical, molecular, and brain MRI findings of 14 individuals
.
Am J Med Genet
.
2006
;
140
(
4
):
331
9
.
8.
Szecowka
K
,
Misiak
B
,
Laczmanska
I
,
Frydecka
D
,
Moustafa
AA
.
Copy number variations and schizophrenia
.
Mol Neurobiol
.
2023
;
60
(
4
):
1854
64
.
9.
Kushima
I
,
Aleksic
B
,
Nakatochi
M
,
Shimamura
T
,
Shiino
T
,
Yoshimi
A
, et al
.
High-resolution copy number variation analysis of schizophrenia in Japan
.
Mol Psychiatry
.
2017
;
22
(
3
):
430
40
.
10.
Jarskog
LF
,
Gilmore
JH
,
Selinger
ES
,
Lieberman
JA
.
Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia
.
Biol Psychiatry
.
2000
;
48
(
7
):
641
50
.
11.
Tsai
MC
,
Liou
CW
,
Lin
TK
,
Lin
IM
,
Huang
TL
.
Bcl-2 associated with positive symptoms of schizophrenic patients in an acute phase
.
Psychiatry Res
.
2013
;
210
(
3
):
735
8
.
12.
Gou
M
,
Pan
S
,
Tong
J
,
Zhou
Y
,
Han
J
,
Xie
T
, et al
.
Effects of microRNA-181b-5p on cognitive deficits in first-episode patients with schizophrenia: mediated by BCL-2
.
J Psychiatr Res
.
2021
;
136
:
358
65
.
13.
Jarskog
LF
,
Glantz
LA
,
Gilmore
JH
,
Lieberman
JA
.
Apoptotic mechanisms in the pathophysiology of schizophrenia
.
Prog Neuro-Psychopharmacol Biol Psychiatry
.
2005
;
29
(
5
):
846
58
.
14.
Hunsberger
J
,
Austin
DR
,
Henter
ID
,
Chen
G
.
The neurotrophic and neuroprotective effects of psychotropic agents
.
Dialogues Clin Neurosci
.
2009
;
11
(
3
):
333
48
.
15.
Baek
KS
,
Ahn
S
,
Lee
J
,
Kim
JH
,
Kim
HG
,
Kim
E
, et al
.
Immunotoxicological effects of aripiprazole: in vivo and in vitro studies
.
Korean J Physiol Pharmacol
.
2015
;
19
(
4
):
365
72
.
You do not currently have access to this content.